Home
|
中文版
|
Web Mail
|
登入
業務範圍
FAQ
資料服務
搜尋
藥品審查業務
醫藥科技評估業務(HTA)
指標案件
醫療器材業務
諮詢服務
新藥查驗登記(NDA)
銜接性試驗評估申請案(BSE)
臨床試驗審查(IND)
原料藥主檔案(DMF)
新醫療器材審查相關
醫藥科技評估
產學會議記錄
中心文獻
搜尋
財團法人醫藥品查驗中心
>
English
>
Regulations
>
Drug Registration
Profile
Orangization
Regulations
Drug Registration
Clinical Trial
Bridging Study
BA/BE Study
Pharmacovigilance
Chemical Manufacturing Control
Registration of Medical Devices
Pharmaceutical Affairs
Others
Major Tasks
Consultations
International Relationship
Prospects
Regulations (Drug Registration)
2009/09/30:
Notes of the Assessment of the API DMF & Checklist for Technical Document for the API DMF
2009/09/03:
Amendment to Article 38-1 of the Guideline on Drug Review and Approval
2009/02/13:
Amendment to Article 22-1 of the Guideline on Drug Review and Approval
2008/11/21:
Guideline on the Examination and Registration of Drugs -- Guideline on Biosimilar products
2006/09/01:
Regulations on “Fee Schedule for the Application of Examination and Registration of Pharmaceuticals and Medical Equipment/Apparatus”
2006/02/27:
The Regulations on Disclosing Drug Data
2005/01/07:
Drug Review and Registration Guideline
2001/12/05:
Guidelines on Drug Review and Registration – for Biological In Vitro Diagnostic Reagents
2001/06/28:
628 announcement